845 related articles for article (PubMed ID: 19273710)
1. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.
Iacobuzio-Donahue CA; Fu B; Yachida S; Luo M; Abe H; Henderson CM; Vilardell F; Wang Z; Keller JW; Banerjee P; Herman JM; Cameron JL; Yeo CJ; Halushka MK; Eshleman JR; Raben M; Klein AP; Hruban RH; Hidalgo M; Laheru D
J Clin Oncol; 2009 Apr; 27(11):1806-13. PubMed ID: 19273710
[TBL] [Abstract][Full Text] [Related]
2. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.
Embuscado EE; Laheru D; Ricci F; Yun KJ; de Boom Witzel S; Seigel A; Flickinger K; Hidalgo M; Bova GS; Iacobuzio-Donahue CA
Cancer Biol Ther; 2005 May; 4(5):548-54. PubMed ID: 15846069
[TBL] [Abstract][Full Text] [Related]
3. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.
Brody JR; Costantino CL; Potoczek M; Cozzitorto J; McCue P; Yeo CJ; Hruban RH; Witkiewicz AK
Mod Pathol; 2009 May; 22(5):651-9. PubMed ID: 19270646
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
6. The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study.
Shin SH; Kim HJ; Hwang DW; Lee JH; Song KB; Jun E; Shim IK; Hong SM; Kim HJ; Park KM; Lee YJ; Kim SC
Oncotarget; 2017 Mar; 8(11):17945-17959. PubMed ID: 28160547
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.
Yachida S; White CM; Naito Y; Zhong Y; Brosnan JA; Macgregor-Das AM; Morgan RA; Saunders T; Laheru DA; Herman JM; Hruban RH; Klein AP; Jones S; Velculescu V; Wolfgang CL; Iacobuzio-Donahue CA
Clin Cancer Res; 2012 Nov; 18(22):6339-47. PubMed ID: 22991414
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
9. [Genetic aspects of pancreatic cancer].
Grigor'eva IN; Efimova OV; Suvorova TS; Tov NL
Eksp Klin Gastroenterol; 2014; (10):70-6. PubMed ID: 25911935
[TBL] [Abstract][Full Text] [Related]
10. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
11. RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.
Whittle MC; Izeradjene K; Rani PG; Feng L; Carlson MA; DelGiorno KE; Wood LD; Goggins M; Hruban RH; Chang AE; Calses P; Thorsen SM; Hingorani SR
Cell; 2015 Jun; 161(6):1345-60. PubMed ID: 26004068
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic alterations of familial pancreatic cancers.
Brune K; Hong SM; Li A; Yachida S; Abe T; Griffith M; Yang D; Omura N; Eshleman J; Canto M; Schulick R; Klein AP; Hruban RH; Iacobuzio-Donohue C; Goggins M
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3536-42. PubMed ID: 19064568
[TBL] [Abstract][Full Text] [Related]
13. Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis.
Qin RY; Fang RL; Gupta MK; Liu ZR; Wang DY; Chang Q; Chen YB
World J Gastroenterol; 2004 Jan; 10(1):132-5. PubMed ID: 14695784
[TBL] [Abstract][Full Text] [Related]
14. Intraductal tubular carcinoma of the pancreas: case report with molecular analysis.
Furukawa T; Hatori T; Fukuda A; Fujita I; Yamamoto M
Pancreas; 2009 Mar; 38(2):235-7. PubMed ID: 19238030
[No Abstract] [Full Text] [Related]
15. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS
Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108
[TBL] [Abstract][Full Text] [Related]
16. Evolution and dynamics of pancreatic cancer progression.
Yachida S; Iacobuzio-Donahue CA
Oncogene; 2013 Nov; 32(45):5253-60. PubMed ID: 23416985
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.
Wilentz RE; Su GH; Dai JL; Sparks AB; Argani P; Sohn TA; Yeo CJ; Kern SE; Hruban RH
Am J Pathol; 2000 Jan; 156(1):37-43. PubMed ID: 10623651
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection.
Shen W; Tao GQ; Li DC; Zhu XG; Bai X; Cai B
World J Gastroenterol; 2008 Oct; 14(40):6254-60. PubMed ID: 18985820
[TBL] [Abstract][Full Text] [Related]
19. Role of radiation therapy in the management of locally advanced pancreatic cancer.
Aref A; Berri R
J Clin Oncol; 2012 May; 30(13):1564-5; author reply 1566-7. PubMed ID: 22412127
[No Abstract] [Full Text] [Related]
20. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
